Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma

BORKOSKY SS; GUNDUZ M; NAGATSUKA H; BEDER LB; GUNDUZ E; MAHMOUD AL SHEIKH ALI; ANDREA P. RODRIGUEZ; MEHMET ZEYNEL CILEK; SUSUMU TOMINAGA; YAMANAKA M; SHIMIZU K; NAGAI NURIYUKI

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Springer

Lugar: Berlín/Heidelberg (Alemania); Año: 2008

0171-5216

Loss of heterozygosity (LOH) in the ING family members has been shown in head and neck squamous cell carcinoma (HNSCC) except for ING2. Like all the other members of ING family, ING2, which is located at chromosome 4q35.1, is a promising tumor suppressor gene (TSG). In this study, we performed LOH analysis of ING2 in HNSCC and compared it with clinicopathological variables. Materials and methods We performed LOH analysis in DNAs from 80 paired of normal and HNSCC tissues, using a speciWcally designed microsatellite marker on chromosome 4q35.1, which detects allelic loss of ING2. TP53 mutation analysis and its relationship with ING2 chromosomal deletion were also performed in available 68 of the samples. The correlation between LOH status and clinicopathological characteristics was evaluated by using statistical methods. The overall survival (OS) and disease free survival (DFS) were also determined. Results LOH was detected in 54.6% (30/55) of the informative samples. Statistical signiWcance was obtained between LOH and tumor (T) stage (P = 0.02), application of radiotherapy and chemotherapy. Positive node status (N) appeared to be the only independent prognostic factor for both OS (P = 0.031) and DFS (P = 0.044). Conclusions Our study showed allelic loss of 4q35.1 in HNSCC. The high percentage of LOH suggests ING2 as a candidate TSG in HNSCC. High LOH frequency was statistically associated with advanced T stage, suggesting that ING2 LOH might occur in late stages during HNSCC progression.